ARK Genomic Revolution ETF vs Iris Energy Limited — how do they compare? ARK Genomic Revolution ETF trades at $44.53, while Iris Energy Limited trades at $42.57 (market cap $14.20B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Iris Energy Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | IREN | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $44.55 | $76.41 |
52-Week Low | $24.02 | $17.73 |
Market Cap | — | $14.20B |
Enterprise Value | — | $15.95B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IREN trades at $43.24, up 11.62% in 24 hours, with a neutral technical signal and bearish moving averages. The company reported Q1 2026 revenue of $501.02M and net income of $86.94M, but missed EPS estimates for three consecutive quarters. Recent news highlights a $2.8B AI contract surge and a raised revenue target above $4B, driving investor optimism despite high valuation ratios like a P/E of 51.6.
Outlook is mixed: strong AI contract growth and analyst consensus price target of $84.43 suggest upside, but execution risks, high valuations, and consistent earnings misses pose challenges. Stock sentiment is buoyed by institutional interest, including a new position by California State Teachers Retirement System in Q2 2026.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.
Read more on IREN →